Cytek Biosciences, Inc. (CTKB) Earnings
|
Expand Research on CTKB
| Next EPS Date | 8/12/26 | EPS Growth Rate | -100.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -420.8% | Revenue Growth Rate | +6.6% |
| Average % Move 1-Wk after EPS | -1.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.08 | N/A | N/A | $48.61M | = | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.15 | -$0.10 | -$0.05 | $44.1M | $43.95M | = |  | | Details | |
| 2/26/26 | Q425 | -$0.34 | -$0.02 | -$0.32 | $62.1M | $57.14M | = | | | Details | |
| 11/5/25 | Q325 | -$0.04 | -$0.03 | -$0.01 | $52.3M | $51.03M | = | | | Details | |
| 8/6/25 | Q225 | -$0.04 | -$0.04 | $0.00 | $45.6M | $46.03M | = | | | Details | |
| 5/8/25 | Q125 | -$0.09 | -$0.02 | -$0.07 | $41.5M | $43.82M | = | | | Details | |
| 2/27/25 | Q424 | $0.00 | $0.11 | -$0.11 | $57.5M | $61.49M | = | | | Details | |
| 11/5/24 | Q324 | $0.01 | $0.01 | $0.00 | $51.5M | $50.7M | = | | | Details |
